What Is NAD+ and Why Is It Not a Peptide?
NAD+ appears regularly in discussions about longevity, cellular energy, and metabolic health research, often alongside peptides and other compounds associated with the same field.
This proximity can create the impression that NAD+ belongs to the same category.
However, NAD+ is not a peptide, it is a distinct class of molecule with a different chemical structure, a different biological role, and a different set of research mechanisms from any peptide currently studied in this space.
Understanding what NAD+ actually is,helps to explain why compounds like NAD+ and research peptides are often discussed in the same breadth, even when they are fundamentally different compounds.
What Is NAD+?
NAD+ stands for nicotinamide adenine dinucleotide.
It is a coenzyme (a small molecule that works alongside enzymes to carry out chemical reactions) found in every living cell.
NAD+ functions as a carrier molecule, shuttling electrons between chemical reactions and enabling the metabolic processes that cells depend on to produce energy and maintain their function.
Chemically, NAD+ is composed of two nucleotides (the building blocks of DNA and RNA) joined together: one containing the vitamin B3 derivative nicotinamide, and one containing adenine (one of the four bases that make up DNA).
This nucleotide-based structure is what places NAD+ in an entirely different chemical category from peptides, which are composed of amino acids.
NAD+ exists in two forms that convert between each other during cellular reactions: NAD+ (the oxidised form, which accepts electrons) and NADH (the reduced form, which donates electrons).
This cycling between the two forms is central to how cells generate energy from nutrients.
Why NAD+ Is Not a Peptide
A peptide is a chain of amino acids linked together by peptide bonds.
The number of amino acids determines the length of the chain, and the sequence of those amino acids determines the peptide’s three-dimensional structure and its biological function.
Peptides range from two amino acids (dipeptides) to chains of fifty or more, at which point they are generally classified as proteins.
NAD+ contains no amino acids and no peptide bonds as it is a nucleotide-based coenzyme, not a chain of amino acids.
The two molecules share no structural features.
NAD+ does not bind to the types of receptors that peptides interact with, does not function as a signalling molecule in the way that most research peptides do, and is not synthesised or broken down through the same biological pathways as peptides.
The confusion arises partly because NAD+ is sold and discussed alongside peptides in the longevity and optimisation research space.
Both NAD+ and research peptides are studied in the context of cellular health, ageing, and metabolic function, but they approach these areas through completely different mechanisms.
How NAD+ Works at a Cellular Level
NAD+ is involved in two broad categories of cellular function: energy metabolism and cellular signalling.
Energy Metabolism
The primary role of NAD+ in energy metabolism is as an electron carrier in cellular respiration (the process through which cells convert nutrients into usable energy in the form of ATP, adenosine triphosphate).
During glycolysis (the breakdown of glucose in the cell’s cytoplasm) and the citric acid cycle (the series of reactions that extract energy from nutrients in the mitochondria), NAD+ accepts electrons from metabolic reactions and is converted to NADH.
NADH then carries these electrons to the electron transport chain (a series of protein complexes embedded in the inner mitochondrial membrane), where they are used to generate the majority of the cell’s ATP.
Without adequate NAD+ levels, this process cannot proceed efficiently. Cells become less able to produce the energy they need for their normal functions, which is one of the reasons NAD+ levels have become a focus of research into cellular ageing and metabolic decline.
Cellular Signalling
Beyond its role in energy production, NAD+ is a required substrate (a molecule consumed in a chemical reaction) for two important classes of enzymes studied in the context of cellular health and longevity.
Sirtuins (SIRTs):
- Sirtuins are a family of enzymes that regulate gene expression, DNA repair, and cellular stress responses.
- They are sometimes called longevity enzymes because of their association with lifespan extension in various model organisms.
- Sirtuins require NAD+ to function: without it, sirtuin activity is significantly impaired.
- Research into NAD+ supplementation is partly motivated by the hypothesis that maintaining NAD+ levels supports sirtuin activity, which in turn supports the biological processes associated with healthy cellular ageing.
A 2014 review by Imai et al. explores the importance of NAD+ supplementation. providing evidence for the importance of NAD+ supplementation.
PARP enzymes:
- PARP (poly ADP-ribose polymerase) enzymes are involved in detecting and repairing DNA damage.
- When DNA is damaged, PARP enzymes consume NAD+ as part of the repair process.
- Under conditions of high DNA damage, PARP activity can deplete NAD+ levels significantly, creating a cycle in which cellular stress drives down the very molecule needed for repair and energy production.
Why NAD+ Levels Decline With Age
One of the most consistently documented findings in NAD+ research is that cellular NAD+ levels decline progressively with age.
As the body ages, the enzymes responsible for synthesising NAD+ become less efficient.
At the same time, NAD+ consumption increases because ageing is associated with higher levels of DNA damage and oxidative stress (the accumulation of reactive molecules that damage cellular components), both of which drive PARP and CD38 enzyme activity (another NAD+-consuming enzyme that increases with age and inflammation).
The result is a progressive imbalance between NAD+ production and consumption.
Research has examined the downstream effects of this decline on mitochondrial function, sirtuin activity, DNA repair capacity, and metabolic efficiency.
This is the scientific context that has made NAD+ one of the most actively studied molecules in longevity and cellular health research over the past decade.
Where NAD+ Sits in Peptide Research
Despite the structural difference, NAD+ and research peptides are studied in overlapping biological contexts.
Compounds like MOTS-c, a mitochondria-derived peptide studied for its role in AMPK pathway activation and metabolic regulation, operate in the same cellular environment where NAD+ is central to energy production.
Epitalon, a tetrapeptide studied in relation to cellular ageing and oxidative stress, sits adjacent to the same research area that NAD+ science occupies.
Longevity and cellular health research increasingly examines how different classes of compound, coenzymes, peptides, and other bioactive molecules, interact with overlapping biological pathways.
NAD+ and peptides are studied as part of the same broader effort to understand how cellular function is maintained over time and what happens when it declines.
Curious About NAD+ and Peptide Research?
Understanding how NAD+ relates to the broader landscape of longevity and cellular health research, and how it sits alongside peptide science without belonging to it, can be a useful foundation for anyone navigating this field.
If you are curious about the world of peptide science, you canschedule a consultation with one of our Peptide Therapy specialists.
Frequently Asked Questions (FAQs)
What does NAD+ stand for?
NAD+ stands for nicotinamide adenine dinucleotide. It is a coenzyme found in every living cell, composed of two nucleotides joined together: one containing the vitamin B3 derivative nicotinamide, and one containing adenine. The plus sign refers to its oxidised form, in which it is ready to accept electrons during metabolic reactions.
Why is NAD+ not a peptide?
Peptides are chains of amino acids. NAD+ contains no amino acids and no peptide bonds. It is a nucleotide-based coenzyme with a completely different chemical structure, biological function, and set of mechanisms from any peptide. The two are categorised together in some research and commercial contexts because they are both studied in relation to cellular health and longevity, but this is a contextual association rather than a chemical or biological one.
Why do NAD+ levels decline with age?
NAD+ levels decline with age due to a combination of reduced synthesis efficiency and increased consumption. Ageing is associated with higher levels of DNA damage and chronic inflammation, both of which drive the activity of NAD+-consuming enzymes such as PARP (involved in DNA repair) and CD38 (an enzyme that increases with age and inflammation). The result is a progressive imbalance between how much NAD+ the body produces and how much it uses, with downstream effects on mitochondrial function, energy production, and cellular repair capacity.
DoesNAD+ help with energy or mitochondrial function?
Mitochondria are the primary site of ATP (cellular energy) production, and NAD+ is central to this process. As an electron carrier in the citric acid cycle and the electron transport chain, NAD+ enables the chemical reactions through which mitochondria convert nutrients into usable energy. When NAD+ levels fall, mitochondrial efficiency declines, which is one of the key mechanisms through which NAD+ depletion is proposed to contribute to cellular ageing and reduced metabolic function.
Why is NAD+ often discussed in peptide research if it is not a peptide?
NAD+ and research peptides are studied in overlapping biological contexts: cellular energy production, metabolic regulation, DNA repair, and cellular ageing. Compounds like MOTS-c and Epitalon are peptides studied for their roles in mitochondrial function and cellular longevity, the same domains in which NAD+ research is most active. The association is scientific and contextual rather than structural. Both represent different molecular approaches to understanding and supporting the same underlying biological systems.
Written by Elizabeth Tito, BSc Genetics, MPH
Elizabeth is a science and medical writer specialising in peptide science, longevity medicine, mitochondrial health, metabolic optimisation and regenerative health research. With a BSc in Genetics and a Master’s in Public Health, she combines a strong scientific foundation with experience translating complex biomedical research into clear, clinically informed education for the Peptide Therapy and longevity medicine space. Her work is centred on interpreting emerging peptide, metabolic and longevity research with scientific accuracy, clinical awareness and a clear understanding of how these therapies are being discussed and applied in modern health optimisation.